logo
Protalix BioTherapeutics Appoints Gilad Mamlok as its New Senior Vice President and Chief Financial Officer

Protalix BioTherapeutics Appoints Gilad Mamlok as its New Senior Vice President and Chief Financial Officer

CARMIEL, Israel, July 21, 2025 /PRNewswire/ — Protalix BioTherapeutics, Inc. (NYSE American: PLX), a biopharmaceutical company focused on the development, production and commercialization of recombinant therapeutic proteins produced by its proprietary ProCellEx® plant cell-based protein expression system, today announced the appointment of Gilad Mamlok to serve as the Company's new Senior Vice President and Chief Financial Officer, effective August 24, 2025, succeeding Eyal Rubin. To ensure a seamless transition, Mr. Mamlok has joined the company and is working alongside Mr. Rubin. After his tenure as Chief Financial Officer ends, Mr. Rubin will continue to be available to the Company as necessary until October 2025.
'With his three decades of experience in healthcare and technology companies, Gilad will play a pivotal role in the execution of our growth strategy, and I am delighted to welcome him to the Protalix team,' said Dror Bashan, Protalix's President and Chief Executive Officer. 'I also want to thank Mr. Rubin, both personally and on behalf of Protalix and its Board of Directors, for his unwavering dedication and leadership. Over the last six years, Eyal and I have worked in a close, collaborative manner in the management of the Company. He contributed significantly to Protalix's transformation, strengthening the Company's capital and financial status and preparing the Company for growth. We wish Eyal success in his future endeavors.'
Mr. Mamlok is a seasoned financial executive with three decades of experience in healthcare and technology companies. He has an extensive background in capital markets transactions, mergers and acquisitions, business development and investor relations as well as in corporate governance matters. Most recently, he served as the Chief Financial Officer of TytoCare Ltd., a privately-held company in the remote healthcare space. Prior to his role at TytoCare, Mr. Mamlok served as the Chief Financial Officer of Sol-Gel Technologies Ltd. In this role, he was responsible for an initial public offering and other capital markets transactions, as well as in-licensing and out-licensing transactions. Prior to his role at Sol-Gel, he served in other medical device companies, including Given Imaging which was acquired by Covidien plc in 2014. Mr. Mamlok holds a BA in Economics, magna cum laude, and a Master's degree in Business/Managerial Economics, both from the Tel Aviv University.
About Protalix BioTherapeutics, Inc.Protalix is a biopharmaceutical company focused on the development and commercialization of recombinant therapeutic proteins expressed through its proprietary plant cell-based expression system, ProCellEx. It is the first company to gain U.S. Food and Drug Administration (FDA) approval of a protein produced through plant cell-based in suspension expression system. This unique expression system represents a new method for developing recombinant proteins in an industrial-scale manner. Protalix has licensed to Pfizer Inc. the worldwide development and commercialization rights to taliglucerase alfa for the treatment of Gaucher disease, Protalix's first product manufactured through ProCellEx, excluding in Brazil, where Protalix retains full rights. Protalix's second product, Elfabrio®, was approved by both the FDA and the European Medicines Agency in May 2023.
Protalix has partnered with Chiesi Farmaceutici S.p.A. for the global development and commercialization of Elfabrio. Protalix's development pipeline consists of proprietary versions of recombinant therapeutic proteins that target established pharmaceutical markets, including the following product candidates: PRX–115, a plant cell-expressed recombinant PEGylated uricase for the treatment of uncontrolled gout; PRX–119, a plant cell-expressed long action DNase I for the treatment of NETs–related diseases; and others.
Forward-Looking StatementsTo the extent that statements in this press release are not strictly historical, all such statements are forward-looking, and are made pursuant to the safe-harbor provisions of the Private Securities Litigation Reform Act of 1995. The terms 'expect,' 'anticipate,' 'believe,' 'estimate,' 'project,' 'plan,' 'should' and 'intend' and other words or phrases of similar import are intended to identify forward-looking statements. These forward-looking statements are subject to known and unknown risks and uncertainties that may cause actual future experience and results to differ materially from the statements made. The statements in this press release are valid only as of the date hereof and we disclaim any obligation to update this information, except as may be required by law.
Investor ContactMike Moyer, Managing DirectorLifeSci Advisors+1-617-308-4306mmoyer@lifesciadvisors.com
Logo – https://mma.prnewswire.com/media/999479/5422505/Protalix_Biotherapeutics_Logo.jpg
Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

Wel-Bloom Biotech Launches Wel-ROS6. Black Crystal Roselle Sparks a Surge in High-Concentration Anthocyanins
Wel-Bloom Biotech Launches Wel-ROS6. Black Crystal Roselle Sparks a Surge in High-Concentration Anthocyanins

The Sun

time3 hours ago

  • The Sun

Wel-Bloom Biotech Launches Wel-ROS6. Black Crystal Roselle Sparks a Surge in High-Concentration Anthocyanins

--> Black Crystal Roselle Anthocyanin Levels Surge 17.7x — Wel-Bloom Biotech Elevates Taiwan's Global Ingredient Competitiveness --> Black Crystal Roselle Shakes Up the Anthocyanin Market with 17.7x Natural Concentration --> Taiwan's Black Crystal Roselle Emerges as a Key Player in the Anthocyanin and Health Markets --> Anthocyanin Levels Surge in Black Crystal Roselle — Spotlight on Key Ingredient Wel-ROS6 --> Wel-ROS6 in Black Crystal Roselle Raises the Bar for Health Supplements TAIPEI, TAIWAN - Media OutReach Newswire - 22 July 2025 - Taiwan's leading jelly supplement manufacturer, Wel-Bloom Biotech, recently co-hosted an anthocyanin-focused seminar with LEARN EATiNG, one of the most renowned nutritionist teams in Taiwan. The event highlighted trending international ingredients alongside Taiwan's own Black Crystal Roselle. Attracting around 300 nutrition professionals both online and onsite, the seminar reflected strong industry interest and high expectations for the future of anthocyanin innovation. In recent years, the health supplement market has seen rapid growth, accompanied by a shift in consumer priorities. Today's consumers increasingly believe that 'choosing the right ingredients matters more than simply taking more,' a mindset that is driving innovation in ingredient formulation. According to the 2024 Top 30 Dietary Trends Report, there is growing interest in the synergistic effects of ingredient combinations. For instance, pairing anthocyanins with fish oil offers comprehensive support for overall health, while combining them with collagen enhances beauty and skin wellness. The Black Crystal Roselle, grown locally in Taiwan, contains naturally high levels of anthocyanins and has recently drawn growing interest in the health supplement field for its promising nutritional potential. As one of the keynote speakers, Wel-Bloom Biotech introduced Wel-ROS6®—a proprietary botanical ingredient derived from Black Crystal Roselle. Developed using triple-patented technology, it is cultivated through natural farming methods and smallholder contract farming to ensure consistent quality and traceability. Laboratory data shows that Wel-ROS6® contains 17.7 times more total anthocyanins than standard commercial roselle. Additionally, total phenolic acids and flavonoids are elevated by 1.9 times and 1.3 times, respectively—highlighting its rich phytochemical profile and high functional value. (See Note 1) The event also featured the Food Industry Research and Development Institute's newly proposed 'Food Value Equation': Value = (Sensory Perception × Functional Technology × User Experience) × Amplification Multiplier. This formula highlights the importance of balancing sensory appeal, technological innovation, and user experience—emphasizing that all three elements are essential to creating meaningful value in food products. To meet growing consumer demands for convenience and palatability in health supplements, product development is increasingly focused on factors such as absorption efficiency, flavor optimization, and sustainable sourcing. The rise of 'tasty' health products reflects a major trend in preventive wellness—perfectly aligned with today's mindset of 'eating less, supplementing smarter.' Through its one-stop CDMO (Contract Development and Manufacturing Organization) services, Taiwan's local agriculture can now be transformed from raw materials into globally market-ready products that seamlessly integrate into everyday life. Wel-ROS6®, backed by the support of over 300 health professionals, will be featured alongside other cutting-edge botanical ingredients at the 2025 BIO Asia–Taiwan Exhibition and Vitafoods Asia. We warmly invite you to visit our booth and explore partnership opportunities with Wel-Bloom Biotech to co-create the next generation of best-selling health supplements. Note 1: Testing commissioned to the Food Industry Research and Development Institute: --> Total phenolic content: Measured using the Folin–Ciocalteu colorimetric assay. --> Total flavonoid content: Measured using the AlCl₃–NaNO₂–NaOH colorimetric method (also known as the Aluminum chloride colorimetric assay). Independent testing by the Forecast Research Lab: --> Anthocyanins (Delphinidin chloride, Cyanidin chloride): Quantified using HPLC analysis --> Total anthocyanins: Measured by the pH differential method

AccuKnox Named Top AI Security Startup at Security BSides Bangalore 2025
AccuKnox Named Top AI Security Startup at Security BSides Bangalore 2025

Malaysian Reserve

time3 hours ago

  • Malaysian Reserve

AccuKnox Named Top AI Security Startup at Security BSides Bangalore 2025

Innovator and Leader in AI Security MENLO PARK, Calif., July 22, 2025 /PRNewswire/ — AccuKnox was given the #1 AI Security Startup of 2025 Award by EmergeX: Unveiling Innovation at the influential BSides Bangalore Cybersecurity Conference in Bangalore. AccuKnox presented its Agentic AI runtime security solution. The competition judges were very accomplished CyberSecurity leaders and voted AccuKnox as the leading innovator. The unique and highly differentiated innovation in the area of AI Agentic Security positions AccuKnox ahead of established industry incumbents in addressing a vexing problem in AI Technology Adoption. The recognition positions AccuKnox as the platform leader and innovator poised ahead of established incumbents who offer legacy/pathwork solutions to this complex problem. AccuKnox presented clear user problems when it comes to security issues faced by users wanting to deploy Agentic AI solutions, such as: Automated Red Teaming to understand the LLM guardrails posture Providing visibility into AI pipelines and helping users to identify Shadow AI Securing untrusted models at Runtime using AccuKnox's patented/developed Sandboxing engine Handling PredML as well as GenAI as part of the same platform Securing AI Infra, Apps, and AI Models/Datasets with full Enterprise integration options The following is a summary of the AccuKnox Agent AI solution Sandboxing Agentic AI deployments Securing datasets leveraged by RAGs and model fine-tuning Automated Red teaming of LLMs AI Security Posture Management for managed and unmanaged deployment A real-time demo was showcased that showed how Guardrails of the popular LLM (Anthropic Claude) can be bypassed by simple prompt engineering and how the AccuKnox solution could be used to prevent the attacks at the next level because of sandboxing. AccuKnox AI Security solutions offer the following unique differentiators: During the EmergeX demo, they showcased how easy the asset onboarding process is, which immediately provides a consolidated view to the users about their AI Security Posture. The Agentic AI solution not only talks about Runtime Prompt Firewall but also about sandboxing the Agentic AI solution. There was a question from one of the judges about the licensing model. AccuKnox's licensing model is based on the number of deployed models, which is easy to quantify. AccuKnox presentation at BSides Bangalore can be viewed here Supporting Quotes 'Agentic AI isn't just about automation—it's about intelligent delegation. In a world overwhelmed by complexity, it marks the rise of proactive digital partners that think, plan, and act alongside us,' said Golan Ben-Oni, CIO, IDT Telecom. 'Congratulations to the AccuKnox team for winning the EmergeX: Unveiling Innovation contest! Your demonstration of cutting-edge AI-driven security solutions showcases the transformative potential of agentic AI across the industry,' said Sujatha Yakasiri, Founder – Security BSides Bangalore and W3-CS (Worldwide Women in Cybersecurity). 'AccuKnox's win at BSides Bangalore is more than a trophy—it's a validation of years of deep research, customer obsession, and fearless innovation. As enterprise buyers shift from bulky, outdated tools to nimble, AI-enhanced platforms, AccuKnox stands at the forefront of this wave. We didn't build this for awards—we built it for the enterprise teams stuck with legacy tech that's failing them,' said Rahul Jadav, co-founder, CTO, AccuKnox. 'Winning EmergeX is incredible validation, but we derive immense satisfaction from the fact that clients can adopt AI-technology and deliver shareholder value and do it most safely and securely.' About AccuKnox: AccuKnox is a next-generation CNAPP and Zero Trust security platform purpose-built for the cloud-native era. With its roots in open source and research from Stanford, AccuKnox delivers AI-enhanced detection, automated remediation, and seamless policy enforcement to secure enterprise workloads across Kubernetes, VMs, and multi-cloud environments. To try a demo: Contact:Product Marketing ManagerSyed HadiAccuKnox Photo:

iRobot Launches Roomba® Max 705 Combo Robot + AutoWash™ Dock The Company's Most Advanced 2-in-1 Cleaning System
iRobot Launches Roomba® Max 705 Combo Robot + AutoWash™ Dock The Company's Most Advanced 2-in-1 Cleaning System

Malaysian Reserve

time4 hours ago

  • Malaysian Reserve

iRobot Launches Roomba® Max 705 Combo Robot + AutoWash™ Dock The Company's Most Advanced 2-in-1 Cleaning System

Roomba Max 705 Combo Provides heated mopping, 175x more suction power and first-of-its-kind cover protecting carpets from wet messes BEDFORD, Mass., July 22, 2025 /PRNewswire/ — iRobot Corp. (NASDAQ: IRBT), a leader in consumer robots, today introduced its most powerful and intelligent 2-in-1 robot to date, the Roomba® Max 705 Combo Robot + AutoWash™ Dock. Designed for the busiest homes, the Roomba Max 705 Combo delivers a deep, hands-free clean with 175x more power-lifting suction*, AI-driven technology to avoid clutter left by kids and pets, and a first-of-its-kind roller mop cover that keeps carpets dry. 'Bringing customers an uncompromised clean through cutting-edge technology remains our top priority,' said Gary Cohen, iRobot CEO. 'The Roomba Max 705 Combo combines more than three decades of our category expertise with the latest technology to deliver an elevated cleaning performance that no other 2-in-1 offers today.' A Flagship 2-in-1 for a True Hands-Free Clean As the newest and most advanced 2-in-1 vacuum and mop within iRobot's recently introduced suite of new Roomba robots, the Roomba Max 705 Combo conquers everyday messes – every day. At the heart of the Roomba Max 705 Combo is the all-new PowerSpin™ Roller Mop with PerfectEdge®, iRobot's most advanced mopping system available to date. Continuously washed during use, the mop extends to get deep into corners, while a first-of-its kind protective mop cover automatically activates to prevent wet carpet messes. Integrated ClearView™ Pro LiDAR and PrecisionVision™ AI technology expertly maps homes in 3D, immediately recognizes toys, cords, pet waste, and intelligently navigates around them. Paired with the iRobot's iconic AutoWash Dock, which offers up to 75 days of self-emptying, heated mop washing and drying, self-cleaning, and auto-refilling, the device delivers a truly hands-free cleaning experience. It also features 175x more suction power*, anti-tangle Dual Rubber Brushes, and Dual Edge-Sweeping Brushes to power through everyday messes. Through the Roomba Home App or a voice assistant**, customers can schedule cleaning missions, set no-go zones, or clean by room, object, or floor type. Whether tidying up after dinner or prepping to host a party, the Roomba Max 705 Combo adjusts to every consumer's needs without them ever needing to lift a finger. Pricing & AvailabilityThe Roomba Max 705 Combo Robot + AutoWash Dock is available for pre-sale in Europe (€1099) on followed by North America and Japan later in the press materials are available at *In spot clean mode with full battery compared to Roomba® 600 series robots. **Works with Alexa, Siri, and Google Assistant-enabled devices. Alexa and all related logos are trademarks of or its affiliates. Google and Google Home are trademarks of Google LLC. Siri is a registered trademark of Apple Inc., registered in the U.S. and other countries and regions. About iRobot is a global consumer robot company that designs and builds thoughtful robots and intelligent home innovations that make life better. iRobot introduced the first Roomba robot vacuum in 2002. Today, iRobot is a global enterprise that has sold more than 50 million robots worldwide. iRobot's product portfolio features technologies and advanced concepts in cleaning, mapping and navigation. Working from this portfolio, iRobot engineers are building robots and smart home devices to help consumers make their homes easier to maintain and healthier places to live. For more information about iRobot, please visit

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store